Practical surgical technique using the SMISS approach for lip reduction in involuted lip infantile hemangiomas.
Facial surgical procedure
Infantile hemangioma
Lip hemangioma
Lip reduction
Propranolol
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
28 May 2024
28 May 2024
Historique:
received:
14
04
2023
accepted:
16
05
2024
medline:
29
5
2024
pubmed:
29
5
2024
entrez:
28
5
2024
Statut:
epublish
Résumé
Lip infantile hemangiomas tend to show less volumetric regression and are more susceptible to visible sequelae in the involuted stage. Some of them still require surgical management after propranolol therapy. This study aimed to evaluate the efficacy and safety of the Stepwise, Multi-Incisional, and Single-Stage (SMISS) approach applied to lip reduction for those with involuted lip hemangiomas. A retrospective review was performed to evaluate patients with lip hemangioma who received previous propranolol treatment and underwent the aforementioned procedure. Demographic characteristics, lesion morphology, and medical history were reviewed. The Visual Analog Scale was applied to assess the postoperative appearance. Complications within 12 months postoperatively were recorded. A total of 18 patients with lip hemangioma were eligible. All patients received oral propranolol therapy before surgery, with treatment duration ranging from 6.0 to 23.0 months. Their age at surgery ranged from 2.5 to 9.0 years. The median Visual Analog Scale scores were 8.0, ranging from 4.0 to 10.0. No severe complications were reported. This modified technique based on the SMISS approach has proven reliable and effective in improving the aesthetic outcome for involuted lip infantile hemangiomas. Practical surgical techniques still play an important part in the propranolol era.
Sections du résumé
BACKGROUND
BACKGROUND
Lip infantile hemangiomas tend to show less volumetric regression and are more susceptible to visible sequelae in the involuted stage. Some of them still require surgical management after propranolol therapy. This study aimed to evaluate the efficacy and safety of the Stepwise, Multi-Incisional, and Single-Stage (SMISS) approach applied to lip reduction for those with involuted lip hemangiomas.
METHODS
METHODS
A retrospective review was performed to evaluate patients with lip hemangioma who received previous propranolol treatment and underwent the aforementioned procedure. Demographic characteristics, lesion morphology, and medical history were reviewed. The Visual Analog Scale was applied to assess the postoperative appearance. Complications within 12 months postoperatively were recorded.
RESULTS
RESULTS
A total of 18 patients with lip hemangioma were eligible. All patients received oral propranolol therapy before surgery, with treatment duration ranging from 6.0 to 23.0 months. Their age at surgery ranged from 2.5 to 9.0 years. The median Visual Analog Scale scores were 8.0, ranging from 4.0 to 10.0. No severe complications were reported.
CONCLUSIONS
CONCLUSIONS
This modified technique based on the SMISS approach has proven reliable and effective in improving the aesthetic outcome for involuted lip infantile hemangiomas. Practical surgical techniques still play an important part in the propranolol era.
Identifiants
pubmed: 38807073
doi: 10.1186/s12887-024-04838-4
pii: 10.1186/s12887-024-04838-4
doi:
Substances chimiques
Propranolol
9Y8NXQ24VQ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
368Informations de copyright
© 2024. The Author(s).
Références
Munden A, Butschek R, Tom WL, et al. Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol. 2014;170(4):907–13.
doi: 10.1111/bjd.12804
pubmed: 24641194
pmcid: 4410180
Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet. 2017;390(10089):85–94.
doi: 10.1016/S0140-6736(16)00645-0
pubmed: 28089471
Pandey A, Gangopadhyay AN, Sharma SP, Kumar V, Gopal SC, Gupta DK. Conservative management of ulcerated haemangioma–twenty years experience. Int Wound J. 2009;6(1):59–62.
doi: 10.1111/j.1742-481X.2008.00562.x
pubmed: 19291117
pmcid: 7951731
Chamlin SL, Haggstrom AN, Drolet BA, et al. Multicenter prospective study of ulcerated hemangiomas. J Pediatr. 2007;151(6):684.9.e1.
doi: 10.1016/j.jpeds.2007.04.055
pubmed: 18035154
Chang CS, Kang GC. Efficacious Healing of Ulcerated Infantile Hemangiomas using topical Timolol. Plast Reconstr Surg Glob Open. 2016;4(2):e621.
doi: 10.1097/GOX.0000000000000605
pubmed: 27014550
pmcid: 4778892
Chang SJ, Yu W, Gu Y, et al. Location of infantile hemangioma is a predictor of volumetric sequelae after involution. J Dermatol. 2019;46(5):371–5.
doi: 10.1111/1346-8138.14847
pubmed: 30888067
Costa VA, Haimowitz R, Cheng YI, Wang J, Silverman RA, Bauman NM. Social Impact of Facial Infantile Hemangiomas in Preteen Children. JAMA Otolaryngol Head Neck Surg. 2016;142(1):13–9.
doi: 10.1001/jamaoto.2015.2597
pubmed: 26583696
Lyu D, Zou Y, Jin Y, et al. Stepwise, Multi-incisional, and single-stage Approach to reshape facial Contour after large cutaneous lesion resection. J Craniofac Surg. 2017;28(6):1498–501.
doi: 10.1097/SCS.0000000000003679
pubmed: 28692509
McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988;18(4):1007–19.
doi: 10.1017/S0033291700009934
pubmed: 3078045
Chen WL, Zhang B, Li JS, et al. Liquid nitrogen cryotherapy of lip mucosa hemangiomas under inhalation general anesthesia with sevoflurane in early infancy. Ann Plast Surg. 2009;62(2):154–7.
doi: 10.1097/SAP.0b013e3181788e76
pubmed: 19158525
Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735–46.
doi: 10.1056/NEJMoa1404710
pubmed: 25693013
Xu P, Yu Q, Huang H, Zhang W, Li W. Lip infantile hemangiomas involving the Vermillion Border have worse outcomes and prognosis to oral Propranolol Than lesions confined to one side of the Vermillion. J Oral Maxillofac Surg. 2020;78(3):446–54.
doi: 10.1016/j.joms.2019.09.010
pubmed: 31628904
De Castro DK, Ng ZY, Holzer PW, Waner M, Cetrulo CL Jr., Fay A. One-stage Supramaximal full-thickness wedge resection of vascular lip anomalies. J Oral Maxillofac Surg. 2017;75(11):2449–55.
doi: 10.1016/j.joms.2017.03.020
pubmed: 28412265
Qiao C, Zou Y, Qiu Y, Lin X. A simple Approach for the repair of Intermediate-to-large Cheek defects. Ann Plast Surg. 2019;83(4S Suppl 1):S77–81.
doi: 10.1097/SAP.0000000000002091
pubmed: 31513072
Hynes S, Narasimhan K, Courtemanche DJ, Arneja JS. Complicated infantile hemangioma of the lip: outcomes of early versus late resection. Plast Reconstr Surg. 2013;131(3):e373–9.
doi: 10.1097/PRS.0b013e31827c6fe2
Scheuermann-Poley OTM, Tan C, Waner M. Distribution, clinical characteristics, and surgical treatment of lip infantile hemangiomas. JAMA Facial Plast Surg. 2013;15(4):292–304.
doi: 10.1001/jamafacial.2013.883
pubmed: 23752875
Li WY, Chaudhry O, Reinisch JF. Guide to early surgical management of lip hemangiomas based on our experience of 214 cases. Plast Reconstr Surg. 2011;128(5):1117–24.
doi: 10.1097/PRS.0b013e31822b6908
pubmed: 21738083
Chen W, Liu S, Yang C, Yang S. Clinical efficacy of the 595 nm pulsed dye laser in the treatment of childhood superficial hemangioma - analysis of 10-year application in Chinese patients. J Dermatolog Treat. 2015;26(1):54–8.
doi: 10.3109/09546634.2013.806979
pubmed: 23697537
Sebaratnam DF, Rodríguez Bandera AL, Wong LF, Wargon O. Infantile hemangioma. Part 2: management. J Am Acad Dermatol. 2021;85(6):1395–404.
doi: 10.1016/j.jaad.2021.08.020
pubmed: 34419523
Chang L, Gu Y, Yu Z, et al. When to stop propranolol for infantile hemangioma. Sci Rep. 2017;7:43292.
doi: 10.1038/srep43292
pubmed: 28225076
pmcid: 5320547
Yu L, Li LL, Yan P, et al. Clinical characteristics of lip infantile haemangiomas and main risk factors for ulceration: an 8-year retrospective study of 69 Chinese infants. J Eur Acad Dermatol Venereol. 2020;34(9):2135–9.
doi: 10.1111/jdv.16331
pubmed: 32118308